Showing results (1801-1810 of 4,142) with videos related to
Sort By:
Pageof 415
Molecular Carcinogenesis|March 3, 2020
Saccharide analog, 2-deoxy-d-glucose enhances 4-1BB-mediated antitumor immunity via PD-L1 deglycosylationBareun Kim, Ruoxuan Sun, Wonkyung Oh, et al.Molecular Carcinogenesis|March 4, 2020
CtBP1 transactivates RAD51 and confers cisplatin resistance to breast cancer cellsYu Deng, Wanjun Guo, Ning Xu, et al.Molecular Carcinogenesis|April 7, 2020
Comprehensive single institute experience with melanoma TIL: Long term clinical results, toxicity profile, and prognostic factors of responseMichal J Besser, Orit Itzhaki, Guy Ben-Betzalel, et al.Molecular Carcinogenesis|March 21, 2020
Contaminated and misidentified cell lines commonly use in cancer researchSiu Tim Cheung, Stephen L Chan, Kwok Wai LoMolecular Carcinogenesis|September 23, 2020
SIRT2 modulates VEGFD-associated lymphangiogenesis by deacetylating EPAS1 in human head and neck cancerAn Hu, Li-Yun Yang, Jia Liang, et al.Molecular Carcinogenesis|September 14, 2020
Protective role of histone deacetylase 4 from ultraviolet radiation-induced DNA lesionsShanshan Li, Mi Zhou, Kan Ze, et al.Molecular Carcinogenesis|April 8, 2020
Inhibition of Cathepsin D (CTSD) enhances radiosensitivity of glioblastoma cells by attenuating autophagyWang Zheng, Qianping Chen, Chen Wang, et al.Molecular Carcinogenesis|December 7, 2020
Toll-like receptor-4 deficiency inhibits ultraviolet radiation-induced tumor development by modulation of immune and inflammatory responsesIsrar Ahmad, Tahseen H Nasti, Heba M Rihan, et al.Molecular Carcinogenesis|March 8, 2021
FAM129B-dependent activation of NRF2 promotes an invasive phenotype in BRAF mutant melanoma cellsCody J Schmidlin, Wang Tian, Matthew Dodson, et al.Molecular Carcinogenesis|November 24, 2021
NUAK family kinase 2 is a novel therapeutic target for prostate cancerWeiwei Fu, Megan T Zhao, Lucy M Driver, et al.Pageof 415